Clinical Trial Update: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

View source ↗

Summary

A completed Gynecologic Oncology Group trial evaluated changes in brain function (cognitive side effects) in patients with stage I–IV ovarian, primary peritonea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cognitive Side Effects of Cancer Therapy, Malignant Ovarian Epithelial Tumor | Status: COMPLETED